P-206 - A RANDOMIZED PHASE 1 STUDY TO COMPARE THE PHARMACOKINETICS, SAFETY, TOLERABILITY AND IMMUNOGENICITY BETWEEN HLX02, REFERENCE US- AND EU-APPROVED TRASTUZUMAB IN HEALTHY CHINESE MALE VOLUNTEERS.
W. Zhou1, Q. Zhang1, M. Wang1, Y. Yu1, J. Wang1, Y. Wu1, G. Sun2, L. Zhou2, Q. Wang2, J. Zhu2; 1The Second Affiliated Hospital of Soochow University, Soochow, China, 2Shanghai Henlius Biotech, Inc., Shanghai, China.
.jpg "Quanying Zhang, MD, PhD photo")
.png)